Marek Brezula joined InCarda Therapeutics as a Manager in Quality Assurance. Prior to joining the team he has worked in the cGMP space at Gilead Sciences, Genentech, Bayer, and various startups. He has worked on multiple NDA’s including all those supporting the SOVALDI® franchise. His background spans small molecule, biologics and custom cell-based therapies. He brings extensive experience in the areas of Clinical Quality Assurance as well as auditing and data integrity.
Marek holds a B.A in Biology from San Francisco State University.